MDV9300

· Medivation, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDV9300, covering 2016-11-25 to 2016-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]

See pricing